GlobalRPh Clinical TechnologyBeyond LDL-C: Understanding Cardiovascular Risk With PREVENT, ApoB, Lp(a), Non-HDL-C and Advanced Lipid AnalysisIntroducing the GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer, a layered cardiovascular prevention tool that combines the standard lipid panel with advanced lipoprotein markers, derived calculations, kidney and metabolic context, coronary calcium, and the American
Tag: LDL cholesterol
Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy
Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy Review Abstract Purpose: This paper examines current approaches to lipid management in family practice, focusing on risk stratification methods, the role of coronary artery calcium scoring, and implementation of
The Truth About Statin Intolerance Symptoms: Myth or Reality?
The Truth About Statin Intolerance Symptoms Myth or Reality Introduction Statin intolerance represents a major clinical challenge in lipid management and cardiovascular disease prevention. Reported symptoms range from muscle pain and weakness to fatigue and gastrointestinal disturbances, affecting between 5 and 30 percent of patients prescribed
Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?
